Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.

about

Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.

Item

http://www.wikidata.org/entity/Q42129909

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of the cytotoxicity ...... man ovarian cancer cell lines.

@en

Evaluation of the cytotoxicity ...... man ovarian cancer cell lines.

@nl

type

Item

label

Evaluation of the cytotoxicity ...... man ovarian cancer cell lines.

@en

Evaluation of the cytotoxicity ...... man ovarian cancer cell lines.

@nl

prefLabel

Evaluation of the cytotoxicity ...... man ovarian cancer cell lines.

@en

Evaluation of the cytotoxicity ...... man ovarian cancer cell lines.

@nl

P1476

Evaluation of the cytotoxicity ...... uman ovarian cancer cell lines

@en

P2093

Laurent Brard

http://www.w3.org/2001/XMLSchema#string

Tsung-Han Jeff Hsieh

http://www.w3.org/2001/XMLSchema#string

Vijayalakshmi N Ayyagari

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel: new uses for an old drug.

Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor

Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Drug combination studies and their synergy quantification using the Chou-Talalay method

Drug delivery systems: entering the mainstream

Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion.

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.

Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.

P304

e0185111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0185111

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P Díaz-Sylvester

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28931042

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5607185

http://www.w3.org/2001/XMLSchema#string